289 related articles for article (PubMed ID: 1650867)
1. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
[TBL] [Abstract][Full Text] [Related]
2. Enoximone as a bridge to heart transplantation: the Utah experience.
O'Connell JB; Gilbert EM; Renlund DG; Bristow MR
J Heart Lung Transplant; 1991; 10(3):477-81. PubMed ID: 1830222
[TBL] [Abstract][Full Text] [Related]
3. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
[TBL] [Abstract][Full Text] [Related]
4. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
[TBL] [Abstract][Full Text] [Related]
5. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
6. [Use of a new inotropic agent, enoximone, in heart surgery].
Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
Bristow MR; Minobe W; Rasmussen R; Larrabee P; Skerl L; Klein JW; Anderson FL; Murray J; Mestroni L; Karwande SV
J Clin Invest; 1992 Mar; 89(3):803-15. PubMed ID: 1311717
[TBL] [Abstract][Full Text] [Related]
8. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
[TBL] [Abstract][Full Text] [Related]
9. Identification of viable myocardium early after acute myocardial infarction under beta-blockade by enoximone echocardiography.
Natale E; Minardi G; Wang F; Tubaro M; Giovannini E; Vajola SF; Milazzotto F
G Ital Cardiol; 1997 Apr; 27(4):342-8. PubMed ID: 9199952
[TBL] [Abstract][Full Text] [Related]
10. [Enoximone as an alternative to mechanical circulatory support prior to heart transplantation].
Schmid ER; Zollinger A; Turina M; Dieterich HA
Schweiz Med Wochenschr; 1989 Sep; 119(36):1231-6. PubMed ID: 2529633
[TBL] [Abstract][Full Text] [Related]
11. [Enoximone in the hemodynamic evaluation before heart transplantation. A new test].
Pornin M; Allal J; Bouton S; Farge D; Couetil JP; Dreyfus G; Sarkis A; Prevost D; Barraine R; Ourbak P
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():95-101. PubMed ID: 2147842
[TBL] [Abstract][Full Text] [Related]
12. [Enoximone and the therapeutic strategy in patients awaiting emergency cardiac graft].
Dubois-Randé JL; Loisance D; Duval-Moulin AM; Deleuze P; Lellouche D; Tavolaro O; Hittinger L; Benvenuti C; Merlet P; Brun D
Arch Mal Coeur Vaiss; 1989; 82(8):1433-8. PubMed ID: 2529834
[TBL] [Abstract][Full Text] [Related]
13. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
[TBL] [Abstract][Full Text] [Related]
14. [New inotropic agents in the treatment of congestive heart failure].
Freitas M
Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
[TBL] [Abstract][Full Text] [Related]
15. [Enoximone as pharmacologic "bridging" to heart transplantation].
Friedel N; Teebken M; Lemme A; Schüler S; Hetzer R
Z Kardiol; 1991; 80 Suppl 4():27-33. PubMed ID: 1833894
[TBL] [Abstract][Full Text] [Related]
16. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?
Winkel E; Kao W; Fisher SG; Heroux AL; Johnson MR; Costanzo MR
J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431
[TBL] [Abstract][Full Text] [Related]
17. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
[TBL] [Abstract][Full Text] [Related]
18. Chronic therapy of severe heart failure with enoximone.
Gilfrich HJ; Witzke-Gross J; Römer A
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S75-7. PubMed ID: 2480490
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
[TBL] [Abstract][Full Text] [Related]
20. [Tolerance of enoximone in patients with heart failure].
Gilfrich HJ; Dieterich HA
Z Kardiol; 1991; 80 Suppl 4():93-7. PubMed ID: 1833904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
